0001567619-22-013787.txt : 20220707 0001567619-22-013787.hdr.sgml : 20220707 20220707161716 ACCESSION NUMBER: 0001567619-22-013787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GHALIE RICHARD G CENTRAL INDEX KEY: 0001156208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 221071837 MAIL ADDRESS: STREET 1: C/O FAVRILLE, INC STREET 2: 10445 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc1.xml FORM 4 X0306 4 2022-07-05 0 0001262104 MEI Pharma, Inc. MEIP 0001156208 GHALIE RICHARD G C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 0 1 0 0 Chief Medical Officer Common Stock 2022-07-05 4 F 0 8196 0.54 D 28927 D Stock Option (Right to Buy) 0.54 2022-07-05 4 A 0 560000 0.00 A 2032-07-05 Common Stock 560000 560000 D Stock Option (Right to Buy) 2.95 2031-07-01 Common Stock 320000 320000 D Stock Option (Right to Buy) 1.21 2026-03-07 Common Stock 130000 130000 D Stock Option (Right to Buy) 1.38 2026-07-14 Common Stock 25000 25000 D Stock Option (Right to Buy) 2.88 2027-07-07 Common Stock 65000 65000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 130000 130000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 150000 150000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 150000 150000 D Stock Option (Right to Buy) 3.55 2031-05-03 Common Stock 75000 75000 D Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units. One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023. One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. All options are currently exercisable. One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. One-quarter of such options vested on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022. /s/ Brian G. Drazba, as attorney in fact 2022-07-07